Researchers examined complement activation in spondyloarthropathies, before and after initiation of antirheumatic treatment, and the link between complement activation and markers of inflammation and cardiovascular risk.
The prevalence of neuropathic-like pain was found to be high in patients with psoriatic arthritis, a condition that may be associated with higher disease activity and fibromyalgia.
In a post hoc analysis of the ASTRAEA study, researchers evaluated the effect of BMI on subsequent response to abatacept in psoriatic arthritis.
Inflammation, disease duration, and chronic pain were identified as the main factors underlying fatigue experienced by patients with psoriatic arthritis.
Researchers reviewed the long-term certolizumab safety across all its approved indications, including rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis, and Crohn disease.
A higher prevalence of NAFLD was observed among patients with psoriasis without arthritis compared with patients with psoriatic arthritis.
A majority of women with psoriatic arthritis have uneventful pregnancies. However, data suggest increased risks for preterm births and caesarian deliveries.
Can reducing weight and drinking reduce the risk for psoriatic arthritis?
Trough infliximab levels and anti‐drug antibodies may reliably predict a suboptimal response to low-dose, as-needed infliximab in patients with spondyloarthritis.
Researchers of a recent study sought to define a cutoff PASDAS that would effectively discriminate between patients in and not in a state of minimal disease activity.
